{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Neuronal Signal Pathway > FipexideCAS：34161-24-5
Molecular Formula：C20H21ClN2O4
Molecular Weight：388.84
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 34161-24-5 |
| Name | Fipexide |
| Molecular Formula | C20H21ClN2O4 |
| Molecular Weight | 388.84 |
| Solubility | Soluble in DMSO(Need ultrasonic) |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 251-857-4 |
| MDL | MFCD00865385 |
| SMILES | C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C(=O)COC4=CC=C(C=C4)Cl |
| InChIKey | BFUJHVVEMMWLHC-UHFFFAOYSA-N |
| InChI | InChI=1S/C20H21ClN2O4/c21-16-2-4-17(5-3-16)25-13-20(24)23-9-7-22(8-10-23)12-15-1-6-18-19(11-15)27-14-26-18/h1-6，11H，7-10，12-14H2 |
| PubChem CID | 3351 |
| Target Point | Dopamine Transporter;adenylate cyclase |
| Passage | Neuronal Signaling;GPCR & G Protein |
| Background | Fipexide is a piperazine-like antipsychotic compound that has been shown to have a positive effect on cognition through dopaminergic neurotransmission and may be used in Alzheimers disease related research. In addition, Fipexide inhibited adenylate cyclase activity in the striatum. |
| Unit | Bottle |
| Specification | 25mg 50mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
